As of 2022, biosimilar Herzuma (trastuzumab-pkrb) launched at an average sales price of six percent less than Herceptin's ASP, while biosimilar Trazimera (trastuzumab-qyyp) launched at an average sales price of 19 percent less than Herceptin's. This statistic illustrates the wholesale acquisition cost and average sales price of Herceptin (trastuzumab) biosimilars in the United States.
Wholesale acquisition cost (WAC) and average sales price (ASP) of Herceptin (trastuzumab) biosimilars in the U.S. as of 2022
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Amgen. (October 31, 2022). Wholesale acquisition cost (WAC) and average sales price (ASP) of Herceptin (trastuzumab) biosimilars in the U.S. as of 2022 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1275620/wac-and-asp-of-herceptin-trastuzumab-biosimilars-us/
Amgen. "Wholesale acquisition cost (WAC) and average sales price (ASP) of Herceptin (trastuzumab) biosimilars in the U.S. as of 2022." Chart. October 31, 2022. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1275620/wac-and-asp-of-herceptin-trastuzumab-biosimilars-us/
Amgen. (2022). Wholesale acquisition cost (WAC) and average sales price (ASP) of Herceptin (trastuzumab) biosimilars in the U.S. as of 2022. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1275620/wac-and-asp-of-herceptin-trastuzumab-biosimilars-us/
Amgen. "Wholesale Acquisition Cost (Wac) and Average Sales Price (Asp) of Herceptin (Trastuzumab) Biosimilars in The U.S. as of 2022." Statista, Statista Inc., 31 Oct 2022, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1275620/wac-and-asp-of-herceptin-trastuzumab-biosimilars-us/
Amgen, Wholesale acquisition cost (WAC) and average sales price (ASP) of Herceptin (trastuzumab) biosimilars in the U.S. as of 2022 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1275620/wac-and-asp-of-herceptin-trastuzumab-biosimilars-us/ (last visited November 10, 2024)
Wholesale acquisition cost (WAC) and average sales price (ASP) of Herceptin (trastuzumab) biosimilars in the U.S. as of 2022 [Graph], Amgen, October 31, 2022. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1275620/wac-and-asp-of-herceptin-trastuzumab-biosimilars-us/
